Point-of-Care Ultrasound Device Market Size, Share, Growth, Trend And Forecast 2021-2027

Published Jul 12, 2022 

David Thomus
By David Thomus

55 Articles

Diagnostic ultrasound, also called sonography or diagnostic medical sonography, is an imaging method that uses sound waves to produce images of structures within the body. The images can provide valuable information for diagnosing and directing treatment for a variety of diseases and conditions. Point-of-care ultrasound refers to the practice of trained medical professionals using ultrasound to diagnose problems wherever a patient is being treated. The increasing prevalence of cardiovascular and chronic diseases attributes to the surging demand for better diagnosis and treatment, thus supporting market growth. Additionally, the increased prevalence of musculoskeletal disorders due to improper nutrition is also a significant factor contributing to the global point of care ultrasound market. Thus, the global point-of-care ultrasound device market to grow at an exponential CAGR of ~9% during the forecast period.

For a detailed analysis of the application in the point-of-care ultrasound device market browse through

On the basis of application, the market is categorized into emergency medicine, cardiology, obstetrics and gynecology, musculoskeletal, and others. Among them, in 2020, obstetrics & gynecology had a significant market share in the market. The reasons for the market growth are to diagnose the risk for pregnancy complications and to save the life of the mother and the neonatal. However, the musculoskeletal segment is expected to have significant growth during the forecast period. The increasing number of injuries and accidents is one of the major drivers of the category’s growth. Furthermore, changing lifestyles and improper nutrition are other reasons for the growth of the musculoskeletal segment in foreseeable future.

Based on types, the market has been bifurcated into diagnostics and therapeutics. During the forecast, the diagnostics segment is expected to witness significant growth. the rising prevalence of chronic diseases such as nephrolithiasis and cardiovascular diseases is attributed to the significant market share of the diagnostic segments in 2020. For instance, as per CDC, every year, about 805,000 people in the United States have a heart attack. Among them, the 605,000 are a first heart attack 200,000 happen to people who have already had a heart attack.

For a detailed analysis of the End-users in the point-of-care ultrasound device market browse through

Based on end-users, the market is segmented into hospitals, clinics, and others. Among these, the hospital segment is predicted to have a major market share in the forecast period. Hospitals complement and amplify the effectiveness of many other parts of the health system, providing continuous availability of services for acute and complex conditions. Furthermore, the increasing number of surgeries in hospitals contributes to the development of the market.

For a better understanding of the market adoption of the point-of-care ultrasound device industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of APAC), and Rest of World. During the forecast period, North America is expected to have a higher CAGR due to higher investment in the healthcare infrastructure and more acceptability towards the adoption and integration of advanced technology in medical facilities. Furthermore, increased awareness about better health and increasing investments in health insurance contributes to the market in the along with the increasing prevalence of chronic diseases positively drives the medical diagnosis market.

Request for Sample of the report browse through

Some of the major players operating in the market include Abbott Laboratories, Siemens xHealthineers AG, Quidel Corporation, F. Hoffman-La Roche Ltd., Danaher Corporation, Becton Dickinson and Company, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech plc, Instrumentation Laboratory (a Werfen Company)

Point-of-Care Ultrasound Device Market Segmentation

Market Insight, by Portability

• Trolley-based devices

• Handheld devices

Market Insight, by Application

• Emergency Medicine

• Cardiology

• Obstetrics And Gynecology

• Musculoskeletal

• Others

Market Insight, by Type

• Diagnostics

• Therapeutics

Market Insight, by End-users

  • ·Hospitals
  • Clinics
  • Others

Market Insight, by Region

  • North America Point-of-Care Ultrasound Device Market
  • United States
  • Canada
  • Rest of North America

  • Europe Point-of-Care Ultrasound Device Market
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe

  • Asia-Pacific Point-of-Care Ultrasound Device Market
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific

  • Rest of World Point-of-Care Ultrasound Device Market

Top Company Profiles

• Abbott Laboratories

• Siemens Healthineers AG

• Quidel Corporation

• F. Hoffman-La Roche Ltd.

• Danaher Corporation

• Becton Dickinson and Company

• Chembio Diagnostics

• EKF Diagnostics

• Trinity Biotech plc

• Instrumentation Laboratory (a Werfen Company)